Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New probe aims to stop post-polypectomy bleeding in high-risk patients

NCT ID NCT02875353

First seen Jun 24, 2026 · Last updated Jun 24, 2026

Summary

This study tests a special probe that checks blood flow in ulcers left after colon polyp removal. The goal is to see if using this probe to guide treatment can prevent delayed bleeding, especially in patients taking blood thinners or with large polyps. About 180 high-risk adults will be randomly assigned to either standard care or probe-guided care, and bleeding rates will be compared over 30 days.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DELAYED POST-POLYPECTOMY INDUCED ULCER HEMORRHAGE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Kaiser Permanente-Downey Medical Center

    Downey, California, 90242, United States

  • University of California, Los Angeles, Ronald Reagan Medical Center

    Los Angeles, California, 90095, United States

  • VA Greater Los Angeles Healthcare System, West Los Angeles, CA

    West Los Angeles, California, 90073-1003, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Doppler endoscopic probe (a device that detects blood flow)

What this could lead to

If successful, this device could become a standard tool to prevent dangerous delayed bleeding after colon polyp removal, especially for patients on blood thinners.

What could go wrong

This is a relatively small, early-stage trial (180 participants) and the device may not reduce bleeding rates significantly compared to standard care. The procedure also carries its own minor risks.

Conditions

The condition(s) this trial relates to.

polyp of colon

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.